bromodeoxyuridine has been researched along with piroxicam in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| D'Ambrosio, SM; Ding, H; Gibson-D'Ambrosio, R; Han, C; Steele, VE | 1 |
| Chiu, LC; Ooi, VE; Tong, KF | 1 |
3 other study(ies) available for bromodeoxyuridine and piroxicam
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Piroxicam selectively inhibits the growth of premalignant and malignant human oral cell lines by limiting their progression through the S phase and reducing the levels of cyclins and AP-1.
Topics: Base Sequence; Bromodeoxyuridine; Cell Division; Cell Line; Cell Survival; Cyclooxygenase Inhibitors; Dinoprostone; DNA Primers; Humans; Mouth Mucosa; Mouth Neoplasms; Piroxicam; Polymerase Chain Reaction; Precancerous Conditions; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured | 2003 |
Cytostatic and cytotoxic effects of cyclooxygenase inhibitors and their synergy with docosahexaenoic acid on the growth of human skin melanoma A-375 cells.
Topics: Antineoplastic Agents; Aspirin; Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase Inhibitors; Docosahexaenoic Acids; Drug Synergism; Humans; Indomethacin; Melanoma, Experimental; Piroxicam; Skin Neoplasms; Tetrazolium Salts; Thiazoles | 2005 |